445 related articles for article (PubMed ID: 32192528)
1. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
Barber CEH; Twilt M; Pham T; Currie GR; Benseler S; Yeung RSM; Batthish M; Blanchette N; Guzman J; Lang B; LeBlanc C; Levy DM; O'Brien C; Schmeling H; Soon G; Spiegel L; Whitney K; Marshall DA
Arthritis Res Ther; 2020 Mar; 22(1):53. PubMed ID: 32192528
[TBL] [Abstract][Full Text] [Related]
2. Development of key performance indicators for prehospital emergency care.
Murphy A; Wakai A; Walsh C; Cummins F; O'Sullivan R
Emerg Med J; 2016 Apr; 33(4):286-92. PubMed ID: 26796739
[TBL] [Abstract][Full Text] [Related]
3. Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis.
Cooper SM; Currie GR; Kromm S; Twilt M; Marshall DA
Pediatr Rheumatol Online J; 2023 Apr; 21(1):37. PubMed ID: 37085775
[TBL] [Abstract][Full Text] [Related]
4. Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis.
Barber CE; Patel JN; Woodhouse L; Smith C; Weiss S; Homik J; LeClercq S; Mosher D; Christiansen T; Howden JS; Wasylak T; Greenwood-Lee J; Emrick A; Suter E; Kathol B; Khodyakov D; Grant S; Campbell-Scherer D; Phillips L; Hendricks J; Marshall DA
Arthritis Res Ther; 2015 Nov; 17():322. PubMed ID: 26568556
[TBL] [Abstract][Full Text] [Related]
5. Developing key performance indicators for a tertiary children's hospital network.
Elliot C; Mcullagh C; Brydon M; Zwi K
Aust Health Rev; 2018 Sep; 42(5):491-500. PubMed ID: 30122160
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of key performance indicators for medication management services provided for outpatients.
Lima TM; Aguiar PM; Storpirtis S
Res Social Adm Pharm; 2019 Sep; 15(9):1080-1087. PubMed ID: 30262211
[TBL] [Abstract][Full Text] [Related]
7. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
McErlane F; Armitt G; Cobb J; Bailey K; Cleary G; Douglas S; Lunt L; Rashid A; Sampath S; Shoop-Worrall S; Smith N; Foster H; Thomson W
Rheumatology (Oxford); 2020 Jan; 59(1):137-145. PubMed ID: 31243450
[TBL] [Abstract][Full Text] [Related]
8. Developing guideline-based key performance indicators for recurrent miscarriage care: lessons from a multi-stage consensus process with a diverse stakeholder group.
Hennessy M; Linehan L; Dennehy R; Devane D; Rice R; Meaney S; O'Donoghue K
Res Involv Engagem; 2022 May; 8(1):18. PubMed ID: 35568920
[TBL] [Abstract][Full Text] [Related]
9. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
[TBL] [Abstract][Full Text] [Related]
10. Establishing Key Performance Indicators [KPIs] and Their Importance for the Surgical Management of Inflammatory Bowel Disease-Results From a Pan-European, Delphi Consensus Study.
Morar PS; Hollingshead J; Bemelman W; Sevdalis N; Pinkney T; Wilson G; Dunlop M; Davies RJ; Guy R; Fearnhead N; Brown S; Warusavitarne J; Edwards C; Faiz O
J Crohns Colitis; 2017 Oct; 11(11):1362-1368. PubMed ID: 28961891
[TBL] [Abstract][Full Text] [Related]
11. Development of key performance indicators to capture in measuring the impact of pharmacists in caring for patients with epilepsy in primary healthcare: A Delphi consensual study.
Shawahna R
Epilepsy Behav; 2019 Sep; 98(Pt A):129-138. PubMed ID: 31374468
[TBL] [Abstract][Full Text] [Related]
12. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
Scott C; Chan M; Slamang W; Okong'o L; Petty R; Laxer RM; Katsicas MM; Fredrick F; Chipeta J; Faller G; Pileggi G; Saad-Magalhaes C; Wouters C; Foster HE; Kubchandani R; Ruperto N; Russo R
Clin Rheumatol; 2019 Feb; 38(2):563-575. PubMed ID: 30267356
[TBL] [Abstract][Full Text] [Related]
13. Developing key performance indicators for prescription medication systems.
Spackman E; Clement F; Allan GM; Bell CM; Bjerre LM; Blackburn DF; Blais R; Hazlewood G; Klarenbach S; Nicolle LE; Persaud N; Alessi-Severini S; Tierney M; Wijeysundera HC; Manns B
PLoS One; 2019; 14(1):e0210794. PubMed ID: 30645647
[TBL] [Abstract][Full Text] [Related]
14. Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach.
Fernandes O; Gorman SK; Slavik RS; Semchuk WM; Shalansky S; Bussières JF; Doucette D; Bannerman H; Lo J; Shukla S; Chan WW; Benninger N; MacKinnon NJ; Bell CM; Slobodan J; Lyder C; Zed PJ; Toombs K
Ann Pharmacother; 2015 Jun; 49(6):656-69. PubMed ID: 25780250
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
Bingham CA; Harris JG; Qiu T; Gilbert M; Vora SS; Yildirim-Toruner C; Ferraro K; Lovell DJ; Taylor J; Mannion ML; Weiss JE; Laxer RM; Shishov M; Oberle EJ; Gottlieb BS; Lee TC; Pan N; Burnham JM; Fair DC; Batthish M; Hazen MM; Spencer CH; Morgan EM;
Arthritis Care Res (Hoboken); 2023 Dec; 75(12):2442-2452. PubMed ID: 37308458
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Quality Measures for Inflammatory Arthritis.
Cooper M; Rouhi A; Barber CEH
J Rheumatol; 2018 Feb; 45(2):274-283. PubMed ID: 29142026
[TBL] [Abstract][Full Text] [Related]
17. Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs).
Lunt LE; Shoop-Worrall S; Smith N; Cleary G; McDonagh J; Smith AD; Thomson W; McErlane F
Pediatr Rheumatol Online J; 2020 Nov; 18(1):91. PubMed ID: 33213474
[TBL] [Abstract][Full Text] [Related]
18. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).
Foeldvari I; Klotsche J; Simonini G; Edelsten C; Angeles-Han ST; Bangsgaard R; de Boer J; Brumm G; Torrent RB; Constantin T; DeLibero C; Diaz J; Gerloni VM; Guedes M; Heiligenhaus A; Kotaniemi K; Leinonen S; Minden K; Miranda V; Miserocchi E; Nielsen S; Niewerth M; Pontikaki I; de Vicuna CG; Zilhao C; Yeh S; Anton J
Pediatr Rheumatol Online J; 2019 Oct; 17(1):66. PubMed ID: 31575380
[TBL] [Abstract][Full Text] [Related]
19. The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Miettunen P; Chédeville G; Mazza J; Hofer M; Montobbio C; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):83-90. PubMed ID: 29637336
[TBL] [Abstract][Full Text] [Related]
20. Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada.
Barber CEH; Then KL; Bohm V; Hall M; Marshall DA; Rankin JA; Barnabe C; Hazlewood GS; Li LC; Mosher D; Homik J; MacMullan P; Tsui K; English K; Lacaille D;
J Rheumatol; 2021 Mar; 48(3):326-334. PubMed ID: 33452175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
